Potential applications of using tissue-specific EVs in targeted therapy and vaccinology-Reference-Cited by-同舟云学术

Potential applications of using tissue-specific EVs in targeted therapy and vaccinology

Published:2023-10 Issue: Volume:166 Page:115308
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Lehmann Tomasz P.,Golik Marta,Olejnik Jolanta,Łukaszewska Marianna,Markowska Dominika,Drożdżyńska Martyna,Kotecki Aleksander,Głowacki Maciej,Jagodziński Paweł P.

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference129 articles.

1. Specificities of secretion and uptake of exosomes and other extracellular vesicles for cell-to-cell communication;Mathieu;Nat. Cell Biol.,2019

2. The role of extracellular vesicles in cancer;Kalluri;Cell,2023

3. Membrane protein modification modulates big and small extracellular vesicle biodistribution and tumorigenic potential in breast cancers in vivo;Magoling;Adv. Mater.,2023

4. Exosome-mediated metastasis: communication from a distance;Wortzel;Dev. Cell,2019

5. Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the international society for extracellular vesicles and update of the MISEV2014 guidelines;Théry;J. Extra Vesicles,2018

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Extracellular vesicles as drug delivery systems in therapeutics: current strategies and future challenges;Journal of Pharmaceutical Investigation;2024-09-02

2. Unignored intracellular journey and biomedical applications of extracellular vesicles;Advanced Drug Delivery Reviews;2024-09

3. Adipose-derived stem cell exosomes loaded with icariin attenuated M1 polarization of macrophages via inhibiting the TLR4/Myd88/NF-κB signaling pathway;International Immunopharmacology;2024-08

4. Serum exosomes lncRNAs: TCONS_I2_00013502 and ENST00000363624 are new diagnostic markers for rheumatoid arthritis;Frontiers in Immunology;2024-07-09

5. mRNA Technology and Mucosal Immunization;Vaccines;2024-06-17